HSIC
Price
$74.67
Change
+$0.19 (+0.26%)
Updated
Jul 3 closing price
Capitalization
9.7B
30 days until earnings call
OMI
Price
$9.21
Change
-$0.08 (-0.86%)
Updated
Jul 3 closing price
Capitalization
2.11B
26 days until earnings call
Interact to see
Advertisement

HSIC vs OMI

Header iconHSIC vs OMI Comparison
Open Charts HSIC vs OMIBanner chart's image
Henry Schein
Price$74.67
Change+$0.19 (+0.26%)
Volume$699.01K
Capitalization9.7B
Owens & Minor
Price$9.21
Change-$0.08 (-0.86%)
Volume$606.33K
Capitalization2.11B
HSIC vs OMI Comparison Chart in %
Loading...
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HSIC vs. OMI commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSIC is a StrongBuy and OMI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (HSIC: $74.67 vs. OMI: $9.21)
Brand notoriety: HSIC and OMI are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: HSIC: 44% vs. OMI: 45%
Market capitalization -- HSIC: $9.7B vs. OMI: $2.11B
HSIC [@Medical Distributors] is valued at $9.7B. OMI’s [@Medical Distributors] market capitalization is $2.11B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSIC’s FA Score shows that 1 FA rating(s) are green whileOMI’s FA Score has 1 green FA rating(s).

  • HSIC’s FA Score: 1 green, 4 red.
  • OMI’s FA Score: 1 green, 4 red.
According to our system of comparison, both HSIC and OMI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSIC’s TA Score shows that 4 TA indicator(s) are bullish while OMI’s TA Score has 6 bullish TA indicator(s).

  • HSIC’s TA Score: 4 bullish, 4 bearish.
  • OMI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OMI is a better buy in the short-term than HSIC.

Price Growth

HSIC (@Medical Distributors) experienced а +2.08% price change this week, while OMI (@Medical Distributors) price change was +10.56% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.01%. For the same industry, the average monthly price growth was +7.79%, and the average quarterly price growth was -2.46%.

Reported Earning Dates

HSIC is expected to report earnings on Aug 05, 2025.

OMI is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Medical Distributors (+2.01% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HSIC($9.71B) has a higher market cap than OMI($2.11B). OMI has higher P/E ratio than HSIC: OMI (64.10) vs HSIC (23.50). HSIC YTD gains are higher at: 7.905 vs. OMI (-29.533). HSIC has higher annual earnings (EBITDA): 877M vs. OMI (391M). OMI has more cash in the bank: 243M vs. HSIC (171M). OMI has less debt than HSIC: OMI (2.32B) vs HSIC (2.74B). HSIC has higher revenues than OMI: HSIC (12.3B) vs OMI (10.3B).
HSICOMIHSIC / OMI
Capitalization9.71B2.11B461%
EBITDA877M391M224%
Gain YTD7.905-29.533-27%
P/E Ratio23.5064.1037%
Revenue12.3B10.3B119%
Total Cash171M243M70%
Total Debt2.74B2.32B118%
FUNDAMENTALS RATINGS
HSIC vs OMI: Fundamental Ratings
HSIC
OMI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
7495
SMR RATING
1..100
6297
PRICE GROWTH RATING
1..100
3048
P/E GROWTH RATING
1..100
492
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OMI's Valuation (58) in the Medical Distributors industry is in the same range as HSIC (77). This means that OMI’s stock grew similarly to HSIC’s over the last 12 months.

HSIC's Profit vs Risk Rating (74) in the Medical Distributors industry is in the same range as OMI (95). This means that HSIC’s stock grew similarly to OMI’s over the last 12 months.

HSIC's SMR Rating (62) in the Medical Distributors industry is somewhat better than the same rating for OMI (97). This means that HSIC’s stock grew somewhat faster than OMI’s over the last 12 months.

HSIC's Price Growth Rating (30) in the Medical Distributors industry is in the same range as OMI (48). This means that HSIC’s stock grew similarly to OMI’s over the last 12 months.

OMI's P/E Growth Rating (2) in the Medical Distributors industry is somewhat better than the same rating for HSIC (49). This means that OMI’s stock grew somewhat faster than HSIC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HSICOMI
RSI
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
47%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 9 days ago
54%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 23 days ago
56%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QVML37.010.28
+0.76%
Invesco S&P 500 QVM Multi-factor ETF
PGZ10.540.03
+0.29%
PRINCIPAL REAL ESTATE Income FUND
EAOK26.53N/A
N/A
iShares ESG Aware 30/70 Cnsrv Allc ETF
LFAE115.07N/A
N/A
LifeX 2048 Longevity Income ETF
DFJ85.64-0.26
-0.30%
WisdomTree Japan SmallCap Dividend ETF

HSIC and

Correlation & Price change

A.I.dvisor tells us that HSIC and ZYXI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
+0.26%
ZYXI - HSIC
28%
Poorly correlated
-10.78%
OMI - HSIC
19%
Poorly correlated
-0.86%
COSM - HSIC
13%
Poorly correlated
+1.83%
CAH - HSIC
12%
Poorly correlated
+1.82%
YI - HSIC
11%
Poorly correlated
+1.23%
More

OMI and

Correlation & Price change

A.I.dvisor tells us that OMI and CAH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OMI and CAH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMI
1D Price
Change %
OMI100%
-0.86%
CAH - OMI
31%
Poorly correlated
+1.82%
HSIC - OMI
20%
Poorly correlated
+0.26%
ZYXI - OMI
17%
Poorly correlated
-10.78%
EDAP - OMI
13%
Poorly correlated
+1.27%
COR - OMI
12%
Poorly correlated
+1.74%
More